About FlexoSense
FlexoSense is a company based in Singapore (Singapore) founded in 2016 by Lye-peng Chia. FlexoSense offers products and services including 3D-printed Insole (Standard), 3D-printed Insole (Diabetes), and Smart Insole (Walking Series). FlexoSense operates in a competitive market with competitors including Imbed Biosciences, Sensel, Cresilon, Canatu and Kane Biotech, among others.
- Headquarter Singapore, Singapore
- Founders Lye-peng Chia
-
Sectors
TechnologyHealthcare Industrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Flexosense Pte. Ltd.
-
Annual Revenue
$803.27 (USD)-86as on Mar 31, 2023
-
Net Profit
-$381.78 K (USD)-185as on Mar 31, 2023
-
EBITDA
-$381.78 K (USD)-185as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FlexoSense
FlexoSense offers a comprehensive portfolio of products and services, including 3D-printed Insole (Standard), 3D-printed Insole (Diabetes), and Smart Insole (Walking Series).
Standard insole for promoting everyday walking and foot health.
Insole designed to monitor and support foot health for diabetes patients.
Smart insole for tracking walking patterns and overall health metrics.
Funding Insights of FlexoSense
Investors in FlexoSense
FlexoSense has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include PIER71.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Maritime startups are accelerated by PIER71 in Singapore.
|
Locked | Locked | Locked |
Investor details for FlexoSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FlexoSense
Investment portfolio details for FlexoSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FlexoSense
Detailed financials for FlexoSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flexosense Comparisons
Peer comparison for FlexoSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FlexoSense
FlexoSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Sensel, Cresilon, Canatu and Kane Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Pressure-sensitive multi-touch sensors are manufactured for input applications.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Advanced carbon nanotube materials are developed for industrial uses.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Provider of printed and flexible 3D image sensors
|
Detailed competitors of FlexoSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flexosense
Complete news archive for FlexoSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FlexoSense
FlexoSense was founded in 2016 and raised its 1st funding round 6 years after it was founded.
FlexoSense is headquartered in Singapore, Singapore.
Lye-peng Chia is the current CEO of FlexoSense. They have also founded this company.
Annual revenue of FlexoSense is $803.27 as on Mar 31, 2023.
FlexoSense was established in 2016 in Singapore as a provider of flexible sensors adaptable to various forms for industrial purposes. These sensors are designed for measuring dynamic pressures and strain, with options for adjusting range, precision, accuracy, and resolution. Applications include enabling sensing in healthcare devices, robotics, and consumer electronics, supporting operations in the technology and manufacturing sectors.
FlexoSense's top competitors include Imbed Biosciences, Canatu and Cresilon.
FlexoSense offers 3D-printed Insole (Standard), 3D-printed Insole (Diabetes), and Smart Insole (Walking Series).
FlexoSense has 1 investor. Key investors include PIER71.